Lung cancer progression and metastasis from the prognostic point of view.
Lung cancer is the leading cause of cancer death in men and women worldwide. Since the occurrence of metastases in distant organs is the major reason for mortality of cancer patients, we need to elucidate the underlying mechanisms. Many studies featuring analysis of gene expression, comparative genomic hybridization and loss of heterozygosity analysis have been performed and generated support for the hypothesis that metastatic potential is acquired early in tumorigenesis. Furthermore, it is now clear that the majority of tumor cells have the potential to metastasize. Although many changes in gene expression profiles have been established retrospectively, translational research is now a high priority to enable clinical application and treatment based on laboratory findings.
Department of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research (JFCR), 135-8550 Koto-ku, Tokyo, Japan.
Kentaro
K
Inamura
Yuichi
Y
Ishikawa
D000230:Adenocarcinoma / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000473:pathology; D018450:Disease Progression; D020869:Gene Expression Profiling; D018398:Homeodomain Proteins / Q000235:genetics; D006801:Humans; D008175:Lung Neoplasms / Q000145:classification / Q000235:genetics / Q000401:mortality / Q000473:pathology*; D009362:Neoplasm Metastasis; D018358:Neuroendocrine Tumors / Q000473:pathology; D011379:Prognosis; D014157:Transcription Factors / Q000235:genetics
C086061:HOXB2 protein, human; D018398:Homeodomain Proteins; D014157:Transcription Factors